Exogenous surfactant application in a rat lung ischemia reperfusion injury model: Effects on edema formation and alveolar type II cells

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Dreyer, Niels ^a   Mühlfeld, Christian ^a,b   Fehrenbach, Antonia ^a,c   Pech, Thomas ^d   von Berg, Sebastian ^a   Nagib, Ragi ^d   Richter, Joachim ^a   Wittwer, Thorsten ^d,e   Wahlers, Thorsten ^d,e   Ochs, Matthias ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; LUNG ALVEOLUS; LUNG DISEASE; LUNG EDEMA; MALE; PATHOLOGY; RANDOMIZATION; RAT; REFERENCE VALUE; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; LUNG DISEASES; MALE; PULMONARY ALVEOLI; PULMONARY EDEMA; PULMONARY SURFACTANTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REPERFUSION INJURY;

EID: 40949132936     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-5     Document Type: Article

References (50)

1. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005, 24:1454-1459. 10.1016/j.healun.2004.11.049, 16210116.
2. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, DeMissie E, Kimmel SE. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005, 171:1312-6. 10.1164/rccm.200409-1243OC, 15764726.
3. Granton J. Update on early respiratory failure in the lung transplant recipient. Curr Opin Crit Care 2006, 12:19-24. 10.1097/01.ccx.0000198995.44943.63, 16394779.
4. Ochs M, Nenadic I, Fehrenbach A, Albes JM, Wahlers T, Richter J, Fehrenbach H. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 1999, 160:718-24.
5. Mühlfeld C, Müller K, Pallesen L-P, Richter J, Wittwer T, Wahlers T, Ochs M. Impact of preservation solution on the extent of edema formation and blood-air barrier damage in experimental lung transplantation. Anat Rec 2007, 290:491-500.
6. Novick RJ, Possmayer F, Veldhuizen RA, Menkis AH, McKenzie FN. Surfactant analysis and replacement therapy: a future tool of the lung transplant surgeon?. Ann Thorac Surg 1991, 52:1194-1200.
7. Lewis JF, Novick RJ, Veldhuizen RAW. Surfactant in lung injury and lung transplantation 1997, New York: Springer.
8. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003, 167:490-511. 10.1164/rccm.200207-670SO, 12588712.
9. Notter RH. Lung surfactants. Basic Science and clinical applications 2000, New York: Marcel Dekker.
10. Gross NJ. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 1995, 57:135-150.
11. Goerke J, Clements JA. Alveolar surface tension and lung surfactant. Mechanics of Breathing, part 1, Handbook of Physiology, sec 3: The Respiratory System 1986, 247-261. Bethesda, Md: American Physiological Society, Macklem PT, Mead J.
12. Schmitz G, Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991, 32:1539-1570.
13. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001, 2:33-46. 59567, 11686863, 10.1186/rr36.
14. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996, 62:302-14. 10.1016/0003-4975(96)00333-5, 8678672.
15. Novick RJ. Innovative techniques to enhance lung preservation. J Thorac Cardiovasc Surg 2002, 123:3-5. 10.1067/mtc.2002.120331, 11782748.
16. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003, 65:613-642. 10.1146/annurev.physiol.65.092101.142434, 12517997.
17. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Höfner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004, 351:884-92. 10.1056/NEJMoa033181, 15329426.
18. Novick RJ, MacDonald J, Veldhuizen RA, Wan F, Duplan J, Denning L, Possmayer F, Gilpin AA, Yao LJ, Bjarneson D, Lewis JF. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996, 154:98-104.
19. Hausen B, Rohde R, Hewitt CW, Schroeder F, Beuke M, Ramsamooj R, Schafers HJ, Borst HG. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997, 113:1050-8. 10.1016/S0022-5223(97)70292-7, 9202686.
20. van der Kaaij NP, Haitsma JJ, Kluin J, Lambrecht BN, Lachmann B, de Bruin RW, Bogers AJ. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. Eur J Cardiothorac Surg 2005, 27:774-82. 10.1016/j.ejcts.2004.12.034, 15848313.
21. Strüber M, Fischer S, Niedermeyer J, Warnecke G, Gohrbandt B, Görler A, Simon AR, Haverich A, Hohlfeld JM. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 2007, 133:1620-1625. 10.1016/j.jtcvs.2006.12.057, 17532965.
22. Fukuse T, Albes JM, Takahashi Y, Brandes H, Hausen B, Schäfers HJ. Influence of red blood cells on lung function in an ex vivo rat heart-lung model. J Surg Res 1995, 59:399-404. 10.1006/jsre.1995.1182, 7643600.
23. Fehrenbach H, Tews S, Fehrenbach A, Ochs M, Wittwer T, Wahlers T, Richter J. Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A. Respir Res 2005, 216:60.
24. Weibel ER, Cruz-Orive LM. Morphometric methods. The lung. Scientific Foundations 1997, 333-344. Philadelphia, PA: Lippincott-Raven, Crystal RG, West JB, Weibel ER, Barnes PJ, 2.
25. Wittwer T, Wahlers T, Fehrenbach A, Cornelius JF, Elki S, Ochs M, Fehrenbach H, Albes J, Haverich A, Richter J. Combined use of prostacyclin and higher perfusate temperatures further enhances the superior lung preservation by Celsior solution in the isolated rat lung. J Heart Lung Transplant 1999, 18:684-692. 10.1016/S1053-2498(98)00061-8, 10452345.
26. Fehrenbach H, Ochs M. Studying lung ultrastructure. Methods in Pulmonary Research 1998, 429-454. Basel: Birkhäuser, Uhlig S, Taylor AE.
27. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970, 26:57-60.
28. Bando T, Albes JM, Nüsse T, Wada H, Hitomi S, Wahlers T, Schäfers H. Comparison of euro-collins solution, low-potassium dextran solution containing glucose, and ET-kyoto solution for lung preservation in an extracorporeal rat lung perfusion model. Eur Surg Res 1998, 30:297-304. 10.1159/000008591, 9731097.
29. Fehrenbach H, Schepelmann D, Albes JM, Bando T, Fischer F, Fehrenbach A, Stolte N, Wahlers T, Richter J. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999, 255:84-9. 10.1002/(SICI)1097-0185(19990501)255:1<84::AID-AR10>3.0.CO;2-#, 10321996.
30. Howard CV, Reed MG. Unbiased stereology. Three-dimensional measurement in microscopy 2005, Oxford: Bios, 2.
31. Ochs M. A brief update on lung stereology. J Microsc 2006, 222:188-200. 10.1111/j.1365-2818.2006.01587.x, 16872418.
32. Weibel ER, Hsia CCW, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 2007, 102:459-467. 10.1152/japplphysiol.00808.2006, 16973815.
33. Weibel ER. Stereological Methods: Practical methods for biological morphometry 1979, New York: Academic Press.
34. Vedel-Jensen EB, Gundersen HJG. The rotator. J Microsc 1993, 171:35-44.
35. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 1984, 134:127-136.
36. van Raemdonck D, Strüber M, Venuta F, Vlasselaers D, Wisser W, Erasmus ME. Strategies in the prevention and treatment of ischaemia-reperfusion injury after lung transplantation. Eur Respir Mon 2004, 29:66-88.
37. Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang Oetomo S, Prop J. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 1996, 153:665-70.
38. Hohlfeld JM, Struber M, Ahlf K, Hoeper MM, Fraund S, Krug N, Warnecke G, Harringer W, Haverich A, Fabel H. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999, 13:1037-43. 10.1034/j.1399-3003.1999.13e17.x, 10414401.
39. Koletsis E, Chatzimichalis A, Fotopoulos V, Kokkinis K, Papadimitriou E, Tiniakos D, Marinos E, Bellenis I, Dougenis D. Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology. Exp Biol Med (Maywood) 2003, 228:540-5.
40. Friedrich I, Borgermann J, Splittgerber FH, Brinkmann M, Reidemeister JC, Silber RE, Seeger W, Schmidt R, Gunther A. Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. J Thorac Cardiovasc Surg 2004, 127:335-43. 10.1016/j.jtcvs.2002.10.001, 14762340.
41. Ochs M, Fehrenbach H, Nenadic I, Bando T, Fehrenbach A, Schepelmann D, Albes JM, Wahlers T, Richter J. Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model. Eur Respir J 2000, 15:526-31. 10.1034/j.1399-3003.2000.15.16.x, 10759447.
42. Fehrenbach A, Fehrenbach H, Wittwer T, Ochs M, Wahlers T, Richter J. Evaluation of pulmonary edema: stereological versus gravimetrical analysis. Eur Surg Res 2001, 33:270-8. 10.1159/000049717, 11684833.
43. Ochs M, Fehrenbach H, Richter J. Ultrastructure of canine type II pneumocytes during hypothermic ischemia of the lung: a study by means of conventional and energy filtering transmission electron microscopy and stereology. Anat Rec 2001, 263:118-26. 10.1002/ar.1084, 11360229.
44. Ochs M, Fehrenbach H, Richter J. Occurence of lipid bodies in canine type II pneumocytes during hypothermic lung ischemia. Anat Rec A Discov Mol Cell Evol Biol 2004, 277:287-297. 10.1002/ar.a.20013, 15052656.
45. Mühlfeld C, Liakopoulos OJ, Schaefer IM, Schoendube FA, Richter J, Dörge H. Methylprednisolone fails to preserve pulmonary surfactant and blood-air barrier integrity in a porcine CPB model. J Surg Res
46. Staub NC. Pulmonary edema. Physiol Rev 1974, 54:678-811.
47. Albertine KH. Histopathology of pulmonary edema and the acute respiratory distress syndrome. Pulmonary edema 1998, 37-83. New York: Marcel Dekker, Matthay MA, Ingbar DH.
48. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983, 128:S42-6.
49. Fehrenbach H, Wahlers T, Ochs M, Brasch F, Schmiedl A, Hirt SW, Haverich A, Richter J. Ultrastructural pathology of the alveolar type II pneumocytes of human donor lungs. Electron microscopy, stereology, and microanalysis. Virchows Arch 1998, 432:229-39. 10.1007/s004280050160, 9532002.
50. Pinkerton KE, Lewis J, Mulder AM, Ikegami M, Jobe AH. Surfactant treatment effects on alveolar type II cell morphology in rabbit lungs. J Appl Physiol 1993, 74:1240-7.